GSK plc ADR buy The Goldman Sachs Group, Inc.
Start price
27.02.23
/
50%
€33.00
Target price
27.02.24
-
Performance (%)
18.79%
End price
28.02.24
€39.20
Summary
This prediction ended on 28.02.24 with a price of €39.20. The BUY prediction by The_Goldman_Sachs_Gr finished with a performance of 18.79%. A total of €1.34 was paid as dividends for this prediction. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | 1.478% | 1.478% | 23.353% |
| iShares Core DAX® | 4.015% | 2.971% | 16.492% |
| iShares Nasdaq 100 | 2.755% | 0.503% | 40.029% |
| iShares Nikkei 225® | -0.826% | -5.057% | 14.566% |
| iShares S&P 500 | 2.330% | 0.720% | 30.194% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten